Eric D. Donnenfeld
Chair of Cornea Scientific Advisory BoardDr. Eric D. Donnenfeld, MD., FAAO., is Director of Tenpoint Therapeutics Limited. He is Scientific Advisor of Azura Ophthalmics Ltd. He is the Member of the Medical Advisory Board of Ophthalmology of Engage Technologies Group, Inc. Dr. Donnenfeld serves as a Clinical Advisor at Mimetogen Pharmaceuticals Inc. Dr. Donnenfeld serves as Chairman of U.S. Medical Advisory Board of Amring Pharmaceuticals Inc. since February 2024. He is Member of Scientific and Medical Advisory Board at Avellino Lab USA, Inc. He serves as Member of Clinical Advisory Board of Regener-Eyes LLC. He serves as Board Member of Spectrum Vision Partners, LLC. He serves as Member of Medical Advisory Board of ELIOS Vision Inc. He is Chair of Cornea Scientific Advisory Board at Oculis Holding AG from 2024. He was Co-Chair of Scientific Advisory Board at Oculis Holding AG until 2024. He serves as Director at Visus Therapeutics, Inc. since January 2023. He serves as Member of Medical Advisory Board at CorneaGen Inc. He served as Member of Medical Advisory Board at TECLens, LLC until August 2026. He serves as a Consultant and Clinical Advisor of WaveTec Vision Systems, Inc. He serves as Medical Advisory Board of Ophthalmology at Ocular Innovations, Inc. Dr. Donnenfeld serves as Medical and Scientific Advisor at Aurion Biotech, Inc. He is the Founding Partner of Ophthalmic Consultants Of Long Island. He practices at Ophthalmic Consultants of Long Island. Dr. Donnenfeld is on the editorial Board of nine journals and has participated in over 40 FDA studies. He is in private practice in Rockville Center, NY. He serves as a Clinical Professor of Ophthalmology at New York University Medical Center. He is a National Medical Director of TLC Laser Eye Centers. He was the President of ASCRS. He is in the Presidential succession line for the International Intraocular Implant Society. Dr. Donnenfeld is the Editor in Chief of Cataract and Refractive Surgery Today. Dr. Donnenfeld is the editor-in-chief of EyeWorld. He is also a Member of Investment Team at Visionary Ventures Fund, LLC. Dr. Donnenfeld has served as a Resident Instructor at Manhattan Eye, Ear and Throat Hospital and as a Program Director at North Shore University Hospital. He was a Chief Resident of Manhattan Eye Ear and Throat Hospital. Dr. Donnenfeld served as the President of many professional societies including the Nassau Surgical Society, cornea section of ASCRS, the Ophthalmology Division of the Nassau Academy of Medicine and the International Ocular Microbiology and Immunology Group. He serves as a Physician Advisory Board Member at Strathspey Crown LLC. He has been a Member of Cornea Scientific Advisory Board at Allegro Ophthalmics, LLC since April 25, 2019. He serves as a Co-Chairman of Medical Advisory Board of TrueVision Systems, Inc. He served as the Chairman of The Surgical Advisory Board and a Director at TrueVision Systems, Inc. He has been a Member of International Scientific Advisory Board at LifeGuard Health, LLC since February 12, 2013. He serves as Member of Scientific Advisory Board at LensGen, Inc. He had been a Member of Ophthalmic Advisory Board of NovaBay Pharmaceuticals, Inc. since 2011 until November 2020. He serves as a Trustee of Dartmouth Medical School. He serves as a Member of Scientific Advisory Board at SKS Ocular, LLC. He has been a Director of Sickbay Health Media, Inc. since July 2000. He served on Sickbay Health Media, Inc.'s Medical Board of Advisors. He served as a Member of Scientific and Business Advisors of InSite Vision Incorporated. Dr. Donnenfeld served as a Co-Chairman of Cornea and External Disease at Nassau University Medical Center and Surgical Director of the Lions Eye Bank for Long Island. He has trained more surgeons to perform refractive surgery than any other doctor in New York. He is a Fellow of the American Academy of Ophthalmology and has received its Honor Award, Senior Honor Award, Life Time Achievement Award and Secretariat Award. He serves on the Board of Directors of the American Society of Cataract and Refractive Surgery and Ocular Surgery News. He served as President of the American Society of Cataract and Refractive Surgery. He was a primary investigator of both the excimer laser and femtosecond laser for cataract surgery. He serves as a Member of Scientific Advisory Board at Glaukos Corporation. He has been a Member of International Scientific Advisory Board of Nutriceutical Holdings, LLC since February 12, 2013. Dr. Donnenfeld has designed and patented four instruments for refractive surgery use. He is a respected researcher and innovator and has authored more than 180 papers on cornea, external disease, cataract and refractive surgery, 500 scientific articles and 40 books and book chapters on a range of subjects pertaining to corneal transplantation, refractive cataract surgery and laser vision correction. He is on the editorial Board of 9 journals and has participated in over 60 FDA studies. He completed his Cornea and Refractive Fellowship at Wills Eye Hospital in Philadelphia in 1985. Dr. Donnenfeld is a practicing Opthamologist with Opthamolic Consultants of L. I. He did his ophthalmology residency at Manhattan Eye, Ear and Throat Hospital, NYC. He has written over 200 peer review papers on cornea, external disease, cataract and refractive surgery and 30 book chapters and books. Dr. Donnenfeld graduated Magna Cum Laude from Dartmouth College in 1977. He received his M.D. degree from Dartmouth Medical School in 1980.
公司职务
- 公司名称Oculis Holding AG股票代码OCS职务Chair of Cornea Scientific Advisory Board共事同僚
- RSRiad SherifCEO & Director
- AAAnthony A. RosenbergIndependent Chairman
- SCSylvia CheungChief Financial Officer
- GBGudrun BachmannChief Technology Officer
- BTBjorn TackenbergChief Scientific Officer
- KAKatie A. KazemChief Legal & Compliance Officer
- AMArshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director
- GOGeraldine O'KeeffeIndependent Director
